382310
Didecyldimethylammonium bromide
98%
Synonym(s):
DDAB
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
[CH3(CH2)9]2N(CH3)2Br
CAS Number:
Molecular Weight:
406.53
UNSPSC Code:
12352116
NACRES:
NA.22
PubChem Substance ID:
EC Number:
219-234-1
Beilstein/REAXYS Number:
6492993
MDL number:
assay
98%
form
powder
reaction suitability
core: ammonium
mp
149-151 °C (lit.)
SMILES string
[Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC
InChI
1S/C22H48N.BrH/c1-5-7-9-11-13-15-17-19-21-23(3,4)22-20-18-16-14-12-10-8-6-2;/h5-22H2,1-4H3;1H/q+1;/p-1
InChI key
UMGXUWVIJIQANV-UHFFFAOYSA-M
Application
Didecyldimethylammonium bromide (DDAB) is commonly used as a surfactant and a phase transfer catalyst. It is also used in the preparation of hydrophobic ammonium-based ionic liquid.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Xiangwen Liu et al.
Scientific reports, 3, 1404-1404 (2013-03-09)
Nanomaterials with particular nanostructures which usually possess special properties always attract considerable attention. A novel bimetallic Pt/Cu hexapod nanostructure was prepared by a facile one-pot strategy. The formation mechanism was investigated by the time sequential evolution experiments and the hexapod
Regis Marty et al.
Nucleic acids research, 37(15), 5197-5207 (2009-06-30)
Despite considerable interest and investigations on cationic lipid-DNA complexes, reports on lipid-RNA interaction are very limited. In contrast to lipid-DNA complexes where lipid binding induces partial B to A and B to C conformational changes, lipid-tRNA complexation preserves tRNA folded
C Carbone et al.
Colloids and surfaces. B, Biointerfaces, 167, 337-344 (2018-04-24)
In this work, we aimed at developing an improved topical SLN formulation combining itraconazole delivery with a coating layer of didodecyldimethylammonium bromide, thus repurposing the drug effectiveness by synergistic skin anticancer effectiveness. In order to obtain a stable SLN formulation